How Long Should You Take Mounjaro for Weight Loss?

Is there an official time limit on taking Mounjaro?

Not in the way many people expect. The UK licence for tirzepatide does not set a hard cut-off date. What exists instead is a clinical checkpoint: NICE's appraisal of tirzepatide (TA1026) recommends that continuation is reviewed if a patient has not lost at least 5% of their starting body weight after six months at the highest dose they can tolerate. Pass that checkpoint and there is no automatic stop date; treatment continues as long as the benefit holds and the prescriber is satisfied with the overall clinical picture.

This is a question our prescribers hear most weeks, usually phrased as "will I be on this forever?" The honest answer is that "forever" is the wrong frame. The right frame is: for as long as the underlying health risk justifies it, reviewed regularly, with a clear plan for what happens next.

The contrast with semaglutide (Wegovy) is worth noting here. NICE's appraisal of Wegovy (TA875) places a two-year cap on NHS-funded treatment within specialist services. Mounjaro's TA1026 guidance does not carry an equivalent time cap, which gives prescribers more flexibility when the clinical case is strong.

What actually happens when people stop taking Mounjaro?

The SURMOUNT-1 trial, involving over 2,500 adults with obesity, showed average body-weight reductions of around 20% at 72 weeks with the 15mg dose. That figure gets quoted widely, but what follows it in the data matters just as much. When trial participants stopped the medicine, a substantial proportion of the weight lost was regained over the following year, a pattern seen consistently across the GLP-1 and dual-agonist class.

This reflects biology more than willpower. Mounjaro works partly by reducing appetite signals; when those signals are no longer dampened, hunger returns toward its previous baseline. The NHS patient information for tirzepatide reinforces that the medicine works alongside a reduced-calorie diet and increased activity, not instead of them. Building those habits during treatment is genuinely useful preparation for any eventual step-down, which is exactly why getting the lifestyle piece right during treatment pays dividends later.

None of this means stopping is wrong. Some people reach a stable lower weight, consolidate the behavioural changes, and taper successfully with their prescriber's support. Others find they need ongoing treatment to maintain the health gains. Both are legitimate outcomes; the prescriber's job is to help you work out which applies to you.

How does the titration schedule affect how long treatment takes to show results?

Treatment starts at 2.5mg, a dose whose job is to let your body adjust rather than to drive weight loss directly. Dose increases typically happen in four-week steps, meaning it can take five to six months just to reach the higher therapeutic doses where the larger weight changes occur. If you are wondering whether Mounjaro is working and you are still on 2.5mg or 5mg, you are probably still in the settling-in phase, which is a different question from whether long-term treatment is right for you. For a fuller look at the early timeline, the page on how long Mounjaro takes to work covers those first weeks in detail.

The practical implication for duration is that a fair assessment of the medicine's effect requires enough time at a meaningful dose. Stopping early because results seem slow at 2.5mg is almost always premature. Most prescribers would want to see at least several months at the maintenance dose before drawing conclusions. The full Mounjaro treatment overview sets out the standard UK dose schedule if you want the broader picture.

How should the decision to continue or stop be made?

Between you and your prescriber, full stop. The variables that matter include how much weight you have lost, whether any weight-related conditions (high blood pressure, sleep apnoea, type 2 diabetes) have improved, how well you have tolerated the medicine, and what your situation looks like if treatment ends. These are clinical judgements, not ones a general article can make for you.

If you are considering stopping, or are curious about what that process looks like, the page on when to stop taking Mounjaro covers the clinical decision points in more detail. The broader question of total treatment length from a tirzepatide perspective is explored on how long you should take tirzepatide. And if cost is part of what you are weighing when thinking about the long term, the Mounjaro cost comparison page gives honest context on what private treatment involves financially, including what a legitimate price should include beyond the pen itself.

At nume, every repeat order goes back to a GPhC-registered prescriber for a fresh clinical review, there are no auto-renewals, no subscriptions, and no rubber-stamping. If your progress has stalled or circumstances have changed, that review is the right moment to raise it. Check your eligibility and start a free consultation if you have not yet begun treatment and want a prescriber's view on whether Mounjaro is the right fit for you.